AMNEAL PHARMACEUTICALS, INC. Other Receivables, Net, Current
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Other Receivables, Net, Current of $4.60 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-06
- 2026-06-30: Other Receivables, Net, Current $4.60M.
- 2026-03-31: Other Receivables, Net, Current $6.17M.
- 2025-12-31: Other Receivables, Net, Current $5.29M.
- 2025-09-30: Other Receivables, Net, Current $14.84M.
| Period end | Other Receivables, Net, Current | Other Receivables, Net, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.60M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $6.17M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $5.29M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $14.84M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $16.33M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $20.51M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $4.47M 10-K · filed 2026-02-27 | $9.14M 10-K · filed 2025-02-28 |
| 2024-09-30 | $7.86M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $7.88M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $12.80M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $9.93M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $15.11M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $14.47M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $14.02M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $33.13M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $9.37M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $17.75M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $47.21M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $9.77M 10-K · filed 2023-03-03 | $42.77M 10-K · filed 2022-03-01 |
| 2021-09-30 | $45.30M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $43.88M 10-Q · filed 2021-08-09 | |
| 2020-12-31 | $17.12M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $14.62M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $12.65M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $16.36M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $16.00M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $16.98M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $18.36M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $19.43M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $15.15M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |